Medical Journals

Aquaporins As Targets for Drug Discovery.

Authors:
  • Frigeri Antonio
  • Nicchia Grazia Paola
  • Svelto Maria

From: Department of General and Environmental Physiology and Centre of Excellence in Comparative Genomics (CEGBA), University of Bari, Bari, Italy. a.frigeri@biologia.uniba.it

Current pharmaceutical design

  • Publish Date: 2007
  • ISSN: 1873-4286
  • Volume: 13
  • Issue: 23
  • Pages: 2421-7
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Frigeri Antonio, Nicchia Grazia Paola, Svelto Maria, et al. Aquaporins As Targets for Drug Discovery.. Curr. Pharm. Des. 2007;13:2421-7

Abstract

The intracellular hydric balance is an essential process of mammalian cells. The water movement across cell membranes is driven by osmotic and hydrostatic forces and the speed of this process is dependent on the presence of specific aquaporin water channels. Since the molecular identification of the first water channel, AQP1, by Peter Agre’s group, 13 homologous members have been found in mammals with varying degree of homology. The fundamental importance of these proteins in all living cells is suggested by their genetic conservation in eukaryotic organisms through plants to mammals. A number of recent studies have revealed the importance of mammalian AQPs in both physiology and pathophysiology and have suggested that pharmacological modulation of aquaporins expression and activity may provide new tools for the treatment of variety of human disorders, such as brain edema, glaucoma, tumour growth, congestive heart failure and obesity in which water and small solute transport may be involved. This review will highlight the physiological role and the pathological involvement of AQPs in mammals and the potential use of some recent therapeutic approaches, such as RNAi and immunotherapy, for AQP-related diseases. Furthermore, strategies that can be developed for the discovery of selective AQP-drugs will be introduced and discussed.

Mesh Headings (Keywords): Animals, Aquaporins, Brain, Drug Design, Drug Evaluation, Preclinical, Eye, Humans, Kidney, Membrane Transport Modulators, Neoplasms, Obesity, Salivary Glands, Skin, Water, Water-Electrolyte Balance


Check for Full Text / PubMed Unique Identifier (PMID): 17692010


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.